120 results
Page 2 of 6
8-K
EX-10.1
3ykp7j76
16 Jun 21
Departure of Directors or Certain Officers
5:06pm
8-K
EX-10.4
aev856z
14 Apr 21
Alimera Sciences receives $20 million
9:12am
8-K
EX-10.65
go4a92
6 Jan 20
Entry into a Material Definitive Agreement
8:25am
424B5
scl5w
25 Oct 19
Prospectus supplement for primary offering
3:53pm
8-K
EX-10.64
uzcos0f7uw
25 Oct 19
Alimera Sciences Announces Equity Purchase Agreement for up to
9:00am
8-K
EX-99.1
znrxcp4 hsbqz
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
8-K
bccq afovm9yvt
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
8-K
EX-10.60
qcsyr1q8
19 Jun 19
Departure of Directors or Certain Officers
5:21pm